LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare diseases,... ...
http://in.reuters.com/article/2013/06/20/us-glaxosmithkline-rarediseases-idINBRE95J06O20130620?feedType=RSS&feedName=healthMedical practitioners, on Wednesday, said they are in favour of using inactivated poliovirus vaccine (IPV) in place of the oral polio vaccine (OPV)... ...
http://www.mydigitalfc.com/news/paediatrics-favour-ipv-eradicate-polio-392New programme aims to help companies increase productivity with technology solutions for pharmaceutical and chemical sectors Pfizer Asia Pacific... ...
http://www.dnaindia.com/pressreleases/1850452/press-release-pfizer-gsk-and-siemens-form-r-and-d-consortium-with-astar-s-institute-of-chemical-and-engineering-sciencesCoupon Express, Inc. (OTCQB: CPXP) Coupon Express today announced the following developments: The appointment of John M. Devlin Jr. and Charles... ...
http://www.andhranews.net/Business/2013/Coupon-Express-Announces-Appointment-Additional-26507.htmBRUSSELS - European Union in its first case over pay-for-delay deals that held back sales of cheaper generic drugs Wednesday fined Danish... ...
http://www.newdelhinews.net/index.php/sid/215305547/scat/3a8a80d6f705f8cc